SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stefania Arasi, Giovanni Passalacqua, Lucia Caminiti, Giuseppe Crisafulli, Chiara Fiamingo, Giovanni Battista Pajno, Efficacy and safety of sublingual immunotherapy in children, Expert Review of Clinical Immunology, 2016, 12, 1, 49

    CrossRef

  2. 2
    Marek Jutel, Ioana Agache, Sergio Bonini, A. Wesley Burks, Moises Calderon, Walter Canonica, Linda Cox, Pascal Demoly, Antony J. Frew, Robin O'Hehir, Jörg Kleine-Tebbe, Antonella Muraro, Gideon Lack, Désirée Larenas, Michael Levin, Harald Nelson, Ruby Pawankar, Oliver Pfaar, Ronald van Ree, Hugh Sampson, Alexandra F. Santos, George Du Toit, Thomas Werfel, Roy Gerth van Wijk, Luo Zhang, Cezmi A. Akdis, International consensus on allergy immunotherapy, Journal of Allergy and Clinical Immunology, 2015, 136, 3, 556

    CrossRef

  3. 3
    Giorgio Canonica, Linda Cox, Ruby Pawankar, Carlos E Baena-Cagnani, Michael Blaiss, Sergio Bonini, Jean Bousquet, Moises Calderón, Enrico Compalati, Stephen R Durham, Roy van Wijk, Désirée Larenas-Linnemann, Harold Nelson, Giovanni Passalacqua, Oliver Pfaar, Nelson Rosário, Dermot Ryan, Lanny Rosenwasser, Peter Schmid-Grendelmeier, Gianenrico Senna, Erkka Valovirta, Hugo Van Bever, Pakit Vichyanond, Ulrich Wahn, Osman Yusuf, Sublingual immunotherapy: World Allergy Organization position paper 2013 update, World Allergy Organization Journal, 2014, 7, 1, 6

    CrossRef

  4. 4
    Giovanni Passalacqua, Erkka Valovirta, Allergens and Allergen Immunotherapy, 2014,

    CrossRef

  5. 5
    Giovanni Passalacqua, Giorgio Canonica, Allergens and Allergen Immunotherapy, 2014,

    CrossRef

  6. 6
    Ludger Klimek, Oliver Pfaar, A comparison of immunotherapy delivery methods for allergen immunotherapy, Expert Review of Clinical Immunology, 2013, 9, 5, 465

    CrossRef

  7. 7
    M.F. Martín-Muñoz, F. Pineda, T. Muiños, M. Fontan, S. Nevot, M. Bosque, J. Jurado Palomo, A. Torredemer, L. Valdesoiro, A.M. Martinez Cañavate, C. Pedemonte Marco, Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment, Allergologia et Immunopathologia, 2013, 41, 1, 4

    CrossRef

  8. You have free access to this content8
    Sten Dreborg, Graham Roberts, Susanne Lau, Alexandra F. Santos, Susanne Halken, Arne Høst, The history of pediatric allergy in Europe – From a working group to ESPACI and SP-EAACI, Pediatric Allergy and Immunology, 2013, 24, 1
  9. 9
    Sandra Y. Lin, Bryan Leatherman, Sublingual Immunotherapy, Otolaryngologic Clinics of North America, 2011, 44, 3, 753

    CrossRef

  10. 10
    T. Zuberbier, C. Bachert, P. J. Bousquet, G. Passalacqua, G. Walter Canonica, H. Merk, M. Worm, U. Wahn, J. Bousquet, GA2LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma, Allergy, 2010, 65, 12
  11. 11
    V. Gödicke, F. Hundt, Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline, Allergy, 2010, 65, 12
  12. 12
    Linda Cox, Moises A. Calderon, Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe, Current Medical Research and Opinion, 2010, 26, 12, 2723

    CrossRef

  13. 13
    Jennifer M. Rolland, Leanne M. Gardner, Robyn E. O'Hehir, Allergen-related approaches to immunotherapy, Pharmacology & Therapeutics, 2009, 121, 3, 273

    CrossRef

  14. 14
    Giuseppe Caruso, Valerio Damiani, Lorenzo Salerni, Francesco Maria Passali, Atopy: pediatric ENT manifestations in children, International Journal of Pediatric Otorhinolaryngology, 2009, 73, S19

    CrossRef

  15. 15
    &NA;, CHAPTER 1: INTRODUCTION AND HISTORICAL BACKGROUND TO SUBLINGUAL IMMUNOTHERAPY, World Allergy Organization Journal, 2009, 2, 11, 236

    CrossRef

  16. 16
    &NA;, CHAPTER 8: GUIDELINES AND RECOMMENDATIONS ON SUBLINGUAL IMMUNOTHERAPY, World Allergy Organization Journal, 2009, 2, 11, 265

    CrossRef

  17. 17
    Sarah K. Wise, Jamie Woody, Sarah Koepp, Rodney J. Schlosser, Quality of life outcomes with sublingual immunotherapy, American Journal of Otolaryngology, 2009, 30, 5, 305

    CrossRef

  18. You have free access to this content18
    J. Bousquet, N. Khaltaev, A. A. Cruz, J. Denburg, W. J. Fokkens, A. Togias, T. Zuberbier, C. E. Baena-Cagnani, G. W. Canonica, C. Van Weel, I. Agache, N. Aït-Khaled, C. Bachert, M. S. Blaiss, S. Bonini, L.-P. Boulet, P.-J. Bousquet, P. Camargos, K.-H. Carlsen, Y. Chen, A. Custovic, R. Dahl, P. Demoly, H. Douagui, S. R. Durham, R. Gerth Van Wijk, O. Kalayci, M. A. Kaliner, Y.-Y. Kim, M. L. Kowalski, P. Kuna, L. T. T. Le, C. Lemiere, J. Li, R. F. Lockey, S. Mavale-Manuel, E. O. Meltzer, Y. Mohammad, J. Mullol, R. Naclerio, R. E. O’Hehir, K. Ohta, S. Ouedraogo, S. Palkonen, N. Papadopoulos, G. Passalacqua, R. Pawankar, T. A. Popov, K. F. Rabe, J. Rosado-Pinto, G. K. Scadding, F. E. R. Simons, E. Toskala, E. Valovirta, P. Van Cauwenberge, D.-Y. Wang, M. Wickman, B. P. Yawn, A. Yorgancioglu, O. M. Yusuf, H. Zar, I. Annesi-Maesano, E. D. Bateman, A. Ben Kheder, D. A. Boakye, J. Bouchard, P. Burney, W. W. Busse, M. Chan-Yeung, N. H. Chavannes, A. Chuchalin, W. K. Dolen, R. Emuzyte, L. Grouse, M. Humbert, C. Jackson, S. L. Johnston, P. K. Keith, J. P. Kemp, J.-M. Klossek, D. Larenas-Linnemann, B. Lipworth, J.-L. Malo, G. D. Marshall, C. Naspitz, K. Nekam, B. Niggemann, E. Nizankowska-Mogilnicka, Y. Okamoto, M. P. Orru, P. Potter, D. Price, S. W. Stoloff, O. Vandenplas, G. Viegi, D. Williams, Allergic Rhinitis and its Impact on Asthma (ARIA) 2008, Allergy, 2008, 63,
  19. 19
    Qiang-min Xie, Ximei Wu, Hui-min Wu, Yang-mei Deng, Shui-juan Zhang, Jian-ping Zhu, Xin-wei Dong, Oral administration of allergen extracts from Dermatophagoides farinae desensitizes specific allergen-induced inflammation and airway hyperresponsiveness in rats, International Immunopharmacology, 2008, 8, 12, 1639

    CrossRef

  20. 20
    Mark H. Tucker, Michael S. Tankersley, Perception and practice of sublingual immunotherapy among practicing allergists, Annals of Allergy, Asthma & Immunology, 2008, 101, 4, 419

    CrossRef

  21. 21
    Ariana D. Buchanan, Todd D. Green, Stacie M. Jones, Amy M. Scurlock, Lynn Christie, Karen A. Althage, Pamela H. Steele, Laurent Pons, Rick M. Helm, Laurie A. Lee, A. Wesley Burks, Egg oral immunotherapy in nonanaphylactic children with egg allergy, Journal of Allergy and Clinical Immunology, 2007, 119, 1, 199

    CrossRef

  22. 22
    Ko-Huang Lue, Yung-Hsiang Lin, Hai-Lun Sun, Ko-Hsiu Lu, Jie-Cheng Hsieh, Ming-Chih Chou, Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study, Pediatric Allergy and Immunology, 2006, 17, 6
  23. 23
    A.G. Palma-Carlos, A.S. Santos, M. Branco-Ferreira, A.L. Pregal, M.L. Palma-Carlos, M.E. Bruno, P. Falagiani, G. Riva, Clinical efficacy and safety of preseasonal sublingual immunotherapy with grass pollen carbamylated allergoid in rhinitic patients. A double-blind, placebo-controlled study, Allergologia et Immunopathologia, 2006, 34, 5, 194

    CrossRef

  24. 24
    Eric Leith, Tom Bowen, Joe Butchey, David Fischer, Harold Kim, Bill Moote, Peter Small, Don Stark, Susan Waserman, Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI), Allergy, Asthma & Clinical Immunology, 2006, 2, 2, 47

    CrossRef

  25. 25
    Giovanni Passalacqua, Giorgio Ciprandi, Novel therapeutic interventions for allergic rhinitis, Expert Opinion on Investigational Drugs, 2006, 15, 12, 1615

    CrossRef

  26. 26
    Steven J. McEldowney, Robert K. Bush, Pollen immunotherapy: Selection, prevention, and future directions, Current Allergy and Asthma Reports, 2006, 6, 5, 420

    CrossRef

  27. 27
    Giovanni Passalacqua, Laura Guerra, Federica Fumagalli, Giorgio Walter Canonica, Safety Profile of Sublingual Immunotherapy, Treatments in Respiratory Medicine, 2006, 5, 4, 225

    CrossRef

  28. 28
    Melanie Werner-Klein, Frank Kalkbrenner, Klaus J Erb, Sublingual immunotherapy of allergic diseases, Expert Opinion on Drug Delivery, 2006, 3, 5, 599

    CrossRef

  29. 29
    Paul C. Potter, Update on sublingual immunotherapy, Annals of Allergy, Asthma & Immunology, 2006, 96, 2, S22

    CrossRef

  30. 30
    G. Senti, P. Johansen, J. Martinez Gomez, B. M. Prinz Varicka, T. M. Kündig, Efficacy and Safety of Allergen-Specific Immunotherapy in Rhinitis, Rhinoconjunctivitis, and Bee/Wasp Venom Allergies, International Reviews of Immunology, 2005, 24, 5-6, 519

    CrossRef

  31. 31
    Giorgio Ciprandi, Giovanni Passalacqua, Emerging anti-inflammatory agents for allergic rhinitis, Expert Opinion on Emerging Drugs, 2005, 10, 4, 689

    CrossRef

  32. 32
    Giorgio Ciprandi, Daniela Fenoglio, Ignazio Cirillo, Andrea Vizzaccaro, Alessandra Ferrera, Maria A. Tosca, Francesco Puppo, Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report, Annals of Allergy, Asthma & Immunology, 2005, 95, 1, 38

    CrossRef

  33. 33
    A. Høst, S. Andrae, S. Charkin, C. Diaz-Vázquez, S. Dreborg, P.A. Eigenmann, F. Friedrichs, P. Grinsted, G. Lack, G. Meylan, P. Miglioranzi, A. Muraro, A. Nieto, B. Niggemann, C. Pascual, M.-G. Pouech, F. Rancé, E. Rietschel, M. Wickman, Les tests d'allergie chez l'enfant : pourquoi, qui, quand, et comment tester ?, Revue Française d'Allergologie et d'Immunologie Clinique, 2005, 45, 2, 164

    CrossRef

  34. 34
    James N Francis, Mark Larché, Peptide-based vaccination: where do we stand?, Current Opinion in Allergy and Clinical Immunology, 2005, 5, 6, 537

    CrossRef

  35. 35
    G. Passalacqua, V. Altrinetti, G. Mariani, P. Falagiani, G. Mistrello, R. Brizzolara, G. W. Canonica, M. Bagnasco, Pharmacokinetics of radiolabelled Par j 1 administered intranasally to allergic and healthy subjects, Clinical & Experimental Allergy, 2005, 35, 7
  36. 36
    G. B. Gidaro, F. Marcucci, L. Sensi, C. Incorvaia, F. Frati, G. Ciprandi, The safety of sublingual-swallow immunotherapy: an analysis of published studies, Clinical & Experimental Allergy, 2005, 35, 5
  37. 37
    F. Marcucci, L. Sensi, G. Di Cara, S. Salvatori, M. Bernini, S. Pecora, S. E. Burastero, Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy, Pediatric Allergy and Immunology, 2005, 16, 6
  38. 38
    James N Francis, Stephen R Durham, Adjuvants for allergen immunotherapy: experimental results and clinical perspectives, Current Opinion in Allergy and Clinical Immunology, 2004, 4, 6, 543

    CrossRef

  39. 39
    M. S. Khinchi, L. K. Poulsen, F. Carat, C. André, A. B. Hansen, H.-J. Malling, Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study, Allergy, 2004, 59, 1
  40. 40
    Giovanni Passalacqua, Laura Guerra, Mercedes Pasquali, Carlo Lombardi, Giorgio W. Canonica, Efficacy and safety of sublingual immunotherapy, Annals of Allergy, Asthma & Immunology, 2004, 93, 1, 3

    CrossRef

  41. 41
    A. Bufe, E. Ziegler-Kirbach, E. Stoeckmann, P. Heidemann, K. Gehlhar, T. Holland-Letz, W. Braun, Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study, Allergy, 2004, 59, 5
  42. 42
    Kirsten Skamstrup Hansen, Marianne Søndergaard Khinchi, Per Stahl Skov, Carsten Bindslev-Jensen, Lars K. Poulsen, Hans-Jørgen Malling, Food allergy to apple and specific immunotherapy with birch pollen, Molecular Nutrition & Food Research, 2004, 48, 6
  43. 43
    J Just, E Goudard, A Grimfeld, Immunothérapie spécifique : acquis et avenir, Archives de Pédiatrie, 2004, 11, S74

    CrossRef

  44. 44
    Giorgio Walter Canonica, Enrico Compalati, Federica Fumagalli, Giovanni Passalacqua, Sublingual and oral immunotherapy, Immunology and Allergy Clinics of North America, 2004, 24, 4, 685

    CrossRef

  45. 45
    Giovanni Passalacqua, Enrico Compalati, Laura Guerra, Pierangela Massacane, Federica Fumagalli, Rodrigo Baena-Cagnani, Anthi Rogkakou, Christian Zanella, Giorgio Walter Canonica, Sublingual immunotherapy: what lessons can we draw from recent studies?, Revue Française d'Allergologie et d'Immunologie Clinique, 2004, 44, 7, 584

    CrossRef

  46. 46
    Anthony J. Frew, 25. Immunotherapy of allergic disease, Journal of Allergy and Clinical Immunology, 2003, 111, 2, S712

    CrossRef

  47. 47
    A.M. Cirla, P.E. Cirla, S. Parmiani, S. Pecora, A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year ontrolled study, Allergologia et Immunopathologia, 2003, 31, 1, 31

    CrossRef

  48. 48
    A. Høst, S. Andrae, S. Charkin, C. Diaz-Vázquez, S. Dreborg, P. A. Eigenmann, F. Friedrichs, P. Grinsted, G. Lack, G. Meylan, P. Miglioranzi, A. Muraro, A. Nieto, B. Niggemann, C. Pascual, M-G. Pouech, F. Rancé, E. Rietschel, M. Wickman, Allergy testing in children: why, who, when and how?, Allergy, 2003, 58, 7
  49. 49
    Robert Movérare, Immunological mechanisms of specific immunotherapy with pollen vaccines: implications for diagnostics and the development of improved vaccination strategies, Expert Review of Vaccines, 2003, 2, 1, 85

    CrossRef

  50. 50
    J Just, E Goudard, A Grimfeld, Immunothérapie dans l’asthme de l’enfant, Journal de Pédiatrie et de Puériculture, 2003, 16, 6, 299

    CrossRef

  51. 51
    Missy M. Clifton, Sandra Marchese Johnson, Paula K. Roberson, Jay Kincannon, Thomas D. Horn, Immunotherapy for Recalcitrant Warts in Children Using Intralesional Mumps or Candida Antigens, Pediatric Dermatology, 2003, 20, 3
  52. 52
    Hans-Jørgen Malling, Immunotherapy for rhinitis, Current Allergy and Asthma Reports, 2003, 3, 3, 204

    CrossRef

  53. 53
    R. Lleonart, F. Muñoz, J.L. Eseverri, A. Martínez-Cañabate, A.I. Tabar, C. Pedemonte, Inmunoterapia sublingual en niños, Allergologia et Immunopathologia, 2003, 31, 4, 244

    CrossRef

  54. 54
    F. Mastrandrea, M.R. Nicotra, L. De Vita, G. Coradduzza, A. Minardi, G. Scarcia, M. Manelli, G. Cadario, S. Parmiani, P.G. Natali, Mite antigens enhance ICAM-1 and induce VCAM-1 expression on Human Umbilical Vein Endothelium, Allergologia et Immunopathologia, 2003, 31, 5, 259

    CrossRef

  55. 55
    A. Bufe, Neue Therapeutische Ansätze der Immunmodulation bei allergischen Erkrankungen/Novel Therapeutic Concepts for Immunomodulation of Allergic Diseases, LaboratoriumsMedizin, 2003, 27, 5/6, 201

    CrossRef

  56. 56
    Giorgio Walter Canonica, Giovanni Passalacqua, Noninjection routes for immunotherapy, Journal of Allergy and Clinical Immunology, 2003, 111, 3, 437

    CrossRef

  57. 57
    R. Sambugaro, P. Puccinelli, S.E. Burastero, V. Di Rienzo, sThe efficacy of sublingual immunotherapy for respiratory allergy is not affected by different dosage regimens in the induction phase, Allergologia et Immunopathologia, 2003, 31, 6, 329

    CrossRef

  58. 58
    Jennifer M Rolland, Robyn E O'Hehir, Allergen immunotherapy: Current and new therapeutic strategies, Allergology International, 2002, 51, 4
  59. 59
    J. Bousquet, P. Van Cauwenberge, N. Khaltaev, Executive Summary of the Workshop Report 7–10 December 1999, Geneva, Switzerland, Allergy, 2002, 57, 9
  60. 60
    A. Criado Molina, F. Guerra Pasadas, J.C. Daza Muñoz, C. Moreno Aguilar, E. Almeda Llamas, E. Muñoz Gomariz, P. Font Ugalde, C. Alonso Díaz, M. Germán Cárdenas, P. Sánchez Guijo, Inmunoterapia con un extracto oral de Alternaria en el asma infantil. Eficacia clínica, seguridad, repercusiones sobre parámetros in vivo e in vitro, Allergologia et Immunopathologia, 2002, 30, 6, 319

    CrossRef

  61. 61
    J. Douglass, R. O'Hehir, Specific allergen immunotherapy: time for alternatives?, Clinical & Experimental Allergy, 2002, 32, 1
  62. 62
    T. Ćirković, M. Gavrović-Jankulović, S. Prišić, R. M. Jankov, L. Burazer, O. Vučković, Z. Šporčić, S. Paranos, The influence of a residual group in low-molecular-weight allergoids of Artemisia vulgaris pollen on their allergenicity, IgE- and IgG-binding properties, Allergy, 2002, 57, 11
  63. 63
    Jean Bousquet, Paul van Cauwenberge, Nikolai Khaltaev, Allergic Rhinitis and Its Impact on Asthma, Journal of Allergy and Clinical Immunology, 2001, 108, 5, S147

    CrossRef

  64. 64
    J. Just, F. Sahraoui, A. Grimfeld, Immunothérapie spécifique, un enjeu dans le traitement de l'asthme de l'enfant, Revue Française d'Allergologie et d'Immunologie Clinique, 2001, 41, 1, 90

    CrossRef

  65. 65
    Fulvio Mastrandrea, Immunotherapy in atopic dermatitis, Expert Opinion on Investigational Drugs, 2001, 10, 1, 49

    CrossRef

  66. 66
    M. Bagnasco, G. Passalacqua, G. Villa, C. Augeri, G. Flamigni, E. Borini, P. Falagiani, G. Mistrello, G.W. Canonica, G. Mariani, Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteers, Clinical & Experimental Allergy, 2001, 31, 1
    Direct Link:
  67. 67
    F. Purello-D'Ambrosio, S. Gangemi, R. A. Merendino, S. Isola, P. Puccinelli, S. Parmiani, L. Ricciardi, Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study, Clinical & Experimental Allergy, 2001, 31, 8
  68. 68
    C. Lombardi, S. Gargioni, A. Melchiorre, A. Tiri, P. Falagiani, G. Walter Canonica, G. Passalacqua, Safety of sublingual immunotherapy with monomeric all_ergoid in adults: multicenter post-marketing surveillance study, Allergy, 2001, 56, 10
  69. 69
    Anthony J. Frew, Helen E. Smith, Sublingual immunotherapy, Journal of Allergy and Clinical Immunology, 2001, 107, 3, 441

    CrossRef

  70. 70
    G. Passalacqua, G. Villa, V. Altrinetti, P. Falagiani, G. W. Canonica, G. Mariani, M. Bagnasco, Sublingual swallow or spit?, Allergy, 2001, 56, 6
  71. 71
    F. Marcucci, L. Sensi, F. Frati, G. E. Senna, G. W. Canonica, S. Parmiani, G. Passalacqua, Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implications, Allergy, 2001, 56, 11
  72. 72
    Jennifer M Rolland, Jo Douglass, Robyn E O’Hehir, Allergen immunotherapy: current and new therapeutic strategies, Expert Opinion on Investigational Drugs, 2000, 9, 3, 515

    CrossRef

  73. 73
    G. B. Pajno, L. Morabito, G. Barberio, S. Parmiani, Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites:a double-blind, placebo-controlled study, Allergy, 2000, 55, 9
  74. 74
    P. Van Cauwenberge, C. Bachert , G. Passalacqua , J. Bousquet , G. W. Canonica , S. R. Durham , W. J. Fokkens , P. H. Howarth , V. Lund , H.-J. Malling , N. Mygind , D. Passali , G. K. Scadding , D.-Y. Wang , Consensus statement on the treatment of allergic rhinitis, Allergy, 2000, 55, 2
  75. 75
    J.C. Bessot, R. Stenger, F. de Blay, G. Pauli, Évaluation des nouvelles voies d'administration de la désensibilisation, Revue Française d'Allergologie et d'Immunologie Clinique, 2000, 40, 3, 325

    CrossRef

  76. 76
    H. de Groot, Immunotherapie: effectiviteit en toepasbaarheid in de kindergeneeskunde, Tijdschrift voor kindergeneeskunde, 2000, 68, 2, 183

    CrossRef

  77. 77
    E. Alvarez-Cuesta, E. Gonzélez-Mancebo, Immunotherapy in bronchial asthma, Current Opinion in Pulmonary Medicine, 2000, 6, 1, 50

    CrossRef

  78. 78
    J. Bousquet, P. Demoly, L'avenir des immunothérapies, Revue Française d'Allergologie et d'Immunologie Clinique, 2000, 40, 7, 706

    CrossRef

  79. 79
    Jørgen N. Larsen, Henning Løwenstein, MANUFACTURING AND STANDARDIZING ALLERGEN VACCINES, Immunology and Allergy Clinics of North America, 2000, 20, 3, 609

    CrossRef

  80. 80
    C. Caffarelli, L. G. Sensi, F. Marcucci, G. Cavagni, Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial, Allergy, 2000, 55, 12
  81. 81
    H.-J. Mailing, Allergen-specific immunotherapy. Present state and directions for the future, Allergy, 1999, 54,
  82. 82
    G. Dutau, Autogestion et clés pour une prise en charge plus efficace de l'asthme de l'enfant, Journal de Pédiatrie et de Puériculture, 1999, 12, 5, 285

    CrossRef

  83. 83
    V. Di Rienzo, A. Pagani, S. Parmiani, G. Passalacqua, G.W. Canonica, Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients, Allergy, 1999, 54, 10
  84. 84
    M. Nittner-Marszalska, Specific immunotherapy in allergic diseases, Revue Française d'Allergologie et d'Immunologie Clinique, 1999, 39, 87

    CrossRef

  85. 85
    F. Purello-D'Ambrosio, S. Gangemi, S. Isola, N. La Motta, L. Ricciardi, P. Puccinelli, S. Parmiani, E. Savi, Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both , Allergy, 1999, 54, 9